Myocardial infarction as the presenting manifestation of systemic lupus erythematosus with antiphosphatidylserine antibodies

Annals of Allergy, Asthma and Immunology

Volumn 76, Issue 3, 1996, Pages 266-268

  Jansen, Noel L ^a   Snell, Jeffrey R ^a   Moy, James N ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; GLYCERYL TRINITRATE; HEPARIN; IMMUNOGLOBULIN A ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; HYPERCOAGULABILITY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 0029918443     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63439-4     Document Type: Article

References (11)

1. Kaplan SD, Chartash EK, Pizzarello RA, Furie RA. Cardiac manifestations of the antiphospholipid syndrome. Am Heart J 1992;124:1331-8.
2. Kattwinkel N, Villanueva AG, Labib SB, et al. Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome. Ann Intern Med 1992;116: 974-6.
3. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117: 303-8.
4. Gladman DD, Urowitz MB. Systemic lupus erythematous. Chapt 11, pp 100-16, In: Schmumacher HR, Klippel JH, Koopman WJ, eds. Primer on the Rheumatic Diseases, 10th ed. Arthritis Foundation, 1993.
5. Alarcon-Segovia D, Cardiel MH, Reyes E. Antiphospholipid arterial vasculopathy. J Rheumatol 1989;16: 762-7.
6. Fye KH, Sack KE. Rheumatic diseases. Chapt 31, pp 387-411 In: Stites DP, Terr AI, Parslow TG, eds. Basic and clinical immunology, 8th ed. Appleton and Lange. 1994.
7. Gilman-Sachs A, Lubinski J, Beer AE, et al. Patterns of antiphospholipid antibody specificities. J Clin Lab Immunol 1991;35:83-8.
8. Rote NS, Dostal-Johnson D, Branch DW. Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. Am J Obstet Gynecol 1990;163: 575-84.
9. Falcon CR, Hoffer AM, Forastiero RR, Carreras LO. Clinical significance of various ELISA assays for detecting antiphospholipid antibodies. Throrab-Haem 1990;64:21-5.
10. Bagger PV, Andersen V, Basland B. et al. Anti-cardiolipin antibodies (IgG and IgA) in women with recurrent fetal loss correlate to clinical and serological characteristics of systemic lupus erythematosus. Acta Obstet Gynecol Scand 1993;72:465-9.
11. Lopez LR, Santos ME, Espinoza LR. La-Rosa FG. Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion. Am J Clin Pathol 1992;98:449-54.